Will also add that $0.3M planned spend is for Urbix testwork. This is important for restoring some upside if they proceed with a Toll Treatment strategy.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025